It's always a pleasure to attend the Cytodyn Darwin Contest.
The contest until now has been EXCLUSIVELY won by short-sellers. That's the past.
For the present, the filings, financials, legal situation and trial results are EVEN BETTER for the short thesis than what existed 2 years ago (which, on its own, was already outstanding to short this bioturd). A big mess on all 4 fronts. Beautiful.
And for the near future, there exist no reliable clinical catalyst for longs to change that situation.
Nice.
The price will surely hiccup here or there, but there exist a big black hole sucking life out of this stock price - the financiers without which Cytodyn insiders cannot get rich. The financiers will deal properly with the last naive shareholders.
PS: plus the SEC/DOJ hammer as a cherry on the cake.
News 
Market Data 
Discover 
